0001493152-20-017696.txt : 20200914 0001493152-20-017696.hdr.sgml : 20200914 20200914090022 ACCESSION NUMBER: 0001493152-20-017696 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20200911 ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200914 DATE AS OF CHANGE: 20200914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 201172394 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 11, 2020

Lineage Cell Therapeutics, Inc.

(Exact name of registrant as specified in charter)

California

001-12830

94-3127919

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

2173 Salk Avenue, Suite 200

Carlsbad, California

92008

(Address of principal executive offices)

(Zip Code)

(442) 287-8990

Registrant’s telephone number, including area code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock		LCTX		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.02. Termination of a Material Definitive Agreement.

On September 11, 2020, Lineage Cell Therapeutics, Inc. (“Lineage”) entered into a Lease Termination Agreement (the “Termination Agreement”) with G&I IX Marina Village Research Park LP, a Delaware limited partnership, as successor to BSREP Marina Village Owner LLC, to terminate Lineage’s leases of office and laboratory space located in two buildings in Alameda, California comprised of 22,303 square feet (“1010 Atlantic Premises”) and 8,492 square feet (“1020 Atlantic Premises”). The Lease Termination Agreement is effective with respect to the 1020 Atlantic Premises as of August 31, 2020 and with respect to the 1010 Atlantic Premises as of September 30, 2020. As previously disclosed, the leased space was previously shared with former affiliated companies that have relocated, and Lineage no longer requires this much space. Lineage will continue to occupy approximately 2,432 square feet of the 1010 Atlantic Premises under a new sublease agreement.

In consideration for the termination of the leases, Lineage agreed to pay a termination fee of $130,000 as follows: approximately $42,000 upon execution of the Termination Agreement and approximately $88,000 on or before September 30, 2020. Lineage also agreed to pay amounts due under the terms of the leases through the applicable termination dates, except that no rent is due with respect to the 1020 Atlantic Premises after July 31, 2020. Under a separate agreement, Lineage agreed to pay a termination fee of $30,000 to its current subtenant in the 1010 Atlantic Premises.

Based on the smaller footprint, and after taking into consideration the fees disclosed above, Lineage has reduced its contractual obligations by approximately $780,000 over the remaining life of the original leases through January 31, 2023.

The foregoing description of the terms of the Termination Agreement is qualified in its entirety by the full text of the Termination Agreement, which is filed as Exhibit 10.1 hereto.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
10.1		Lease Termination Agreement dated September 11, 2020
101		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lineage Cell Therapeutics, Inc.

Date: September 14, 2020	By:	/s/ Brandi L. Roberts
	Name:	Brandi L. Roberts
	Title:	Chief Financial Officer

EX-10.1 2 ex10-1.htm

Exhibit 10.1

LEASE TERMINATION AGREEMENT

THIS LEASE TERMINATION AGREEMENT dated September 11, 2020 (this “Agreement”), is entered into by and between G&I IX MARINA VILLAGE RESEARCH PARK LP, a Delaware limited partnership (“Landlord”), and LINEAGE CELL THERAPEUTICS, INC., a California corporation, formerly known as Biotime, Inc., a California corporation (“Tenant”), with reference to the following facts and understandings:

RECITALS

WHEREAS, BSREP Marina Village Owner TRS LLC, a Delaware limited liability company (“Original 1010 Atlantic Landlord”), and Tenant entered into that certain Lease dated December 10, 2015, as amended (the “1010 Atlantic Lease”), for the lease of certain premises (the “1010 Atlantic Premises”), consisting of approximately 22,303 rentable square feet commonly known as Suite 102 located on the first (1^st) floor of that certain office building located at 1010 Atlantic Avenue, Alameda, California. Landlord is the successor-in-interest to Original 1010 Atlantic Landlord under the 1010 Atlantic Lease.

WHEREAS, Tenant and Industrial Microbes, Inc., a Delaware corporation (“Industrial Microbes”), entered into that certain Standard Sublease dated April 7, 2020 (the “Industrial Microbes Sublease”), for the sublease of a portion of the 1010 Atlantic Premises.

WHEREAS, BSREP Marina Village Owner LLC, a Delaware limited liability company (“1020 Atlantic Original Landlord”), and Tenant entered into that certain Amended and Restated Lease dated December 10, 2015, as amended (the “1020 Atlantic Lease”), for the lease of certain premises (the “1020 Atlantic Premises”), consisting of approximately 8,492 rentable square feet commonly known as Suite 100 located on the first (1^st) floor of that certain office building located at 1020 Atlantic Avenue, Alameda, California. Landlord is the successor-in-interest to Original 1020 Atlantic Landlord under the 1020 Atlantic Lease. The 1010 Atlantic Lease and the 1020 Atlantic Lease are collectively referred to herein as the “Leases”.

WHEREAS, concurrently herewith, Landlord is entering into a new lease (the “New 1010 Atlantic Lease”) with Bay Area Disruptor And Startup Support Labs, a California corporation (“Bay Area Disruptor”) for the lease of the 1010 Atlantic Premises.

WHEREAS, concurrently herewith, Tenant and Industrial Microbes are each entering into a new sublease or license agreement (each, a “Bay Area Disruptor Sublease” and collectively the “Bay Area Disruptor Subleases”) with Bay Area Disrupter for the sublease or use of a portion of the 1010 Atlantic Premises (collectively, the “Subleased Premises”).

WHEREAS, as soon as practicable after execution of this Agreement, Landlord shall enter into a new lease (the “New 1020 Atlantic Lease”) with a new tenant (“New 1020 Atlantic Tenant”) for the lease of the 1020 Atlantic Premises.

WHEREAS, the parties desire to terminate both the 1010 Atlantic Lease and the 1020 Atlantic Lease prior to the scheduled expiration date of the Leases, all upon and subject to the terms and conditions hereinafter provided.

1

AGREEMENT

NOW, THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the parties hereto agree as follows:

1. Recitals. The Recitals set forth above are incorporated herein as though set forth in full herein.

2. Termination Consideration. As consideration for Landlord’s agreement to terminate the Leases as hereinafter provided, Tenant hereby agrees to pay Landlord consideration in the amount of One Hundred Thirty Thousand and No/100 Dollars ($130,000.00) (the “Termination Consideration”). The Termination Consideration shall be paid by Tenant’s wire transfer to Landlord or Tenant’s delivery of a check to Landlord as follows: (a) Tenant shall pay to Landlord $42,092.60 (the “Partial Termination Consideration Payment”) concurrently with Tenant’s execution and delivery of this Agreement, and (b) Tenant shall pay to Landlord $87,907.40 (the “Balance of the Termination Consideration”) on or before September 30, 2020. Tenant acknowledges and agrees that (i) the Termination Consideration is fully-earned by Landlord as consideration for, and as a condition to, Landlord’s agreement to terminate the Leases pursuant to this Agreement, and (ii) Landlord would not have entered into this Agreement and agreed to terminate the Leases but for Tenant’s agreement to pay Landlord the Termination Consideration. In addition to the Termination Consideration, Tenant also hereby agrees to pay Landlord a total of $91,401.40 in Deferred Rent (as such term is defined in the Leases) concurrently with Tenant’s execution and delivery of this Agreement.

3. Termination Dates.

(a) The 1020 Atlantic Lease, and all subleases or other tenancies thereunder shall terminate on August 31, 2020 (the “1020 Atlantic Termination Date”), subject to (i) the receipt by Landlord of the Partial Termination Consideration and the Deferred Rent in accordance with the provisions of Section 2 above, and (ii) the vacating and surrendering of the 1020 Atlantic Premises to Landlord by Tenant and any subtenants or other occupants of the 1020 Atlantic Premises with Tenant’s furniture, fixtures, equipment and other personal property removed from the 1020 Atlantic Premises. Following the 1020 Atlantic Termination Date and notwithstanding any breach or default of this Agreement by any party hereto, Tenant shall have no right to occupy the 1020 Atlantic Premises. Provided that Tenant removes all of Tenant’s furniture fixtures, equipment and other personal property from the 1020 Atlantic Premises by September 18, 2020, no further rent will accrue with respect to the 1020 Atlantic Premises after July 31, 2020. If Tenant fails to vacate, surrender and deliver exclusive possession of the 1020 Premises to Landlord with all of Tenant’s furniture fixtures, equipment and other personal property removed from the 1020 Atlantic Premises by September 18, 2020, then, without limitation as to any other rights and remedies of Landlord under the 1020 Atlantic Lease, at law or in equity, Tenant shall be deemed to be a holdover tenant in the 1020 Atlantic Premises subject to the terms and conditions of Article 16 of the 1020 Atlantic Lease, provided however, that, in addition to paying all other amounts due under the 1020 Atlantic Lease, commencing on September 19, 2020, Tenant shall pay to Landlord Base Rent for the 1020 Atlantic Premises in the amount of $30,061.68 per month or $1,002.06 per day until the date that Tenant and any subtenants or other occupants of the 1020 Atlantic Premises vacate and surrender the 1020 Atlantic Premises to Landlord with all of Tenant’s and any subtenants’ or other occupants’ furniture fixtures, equipment and other personal property removed from the 1020 Atlantic Premises.

2

(b) The 1010 Atlantic Lease, and all subleases or other tenancies thereunder, including but not limited to, the Industrial Microbes Sublease shall terminate on September 30, 2020 (the “1010 Atlantic Termination Date”), subject to (i) the receipt by Landlord of the Balance of the Termination Consideration in accordance with the provisions of Section 2 above, and (ii) the vacating and surrendering to Landlord of the 1010 Atlantic Premises (except the Subleased Premises) by Tenant and any subtenants or other occupants of the 1010 Atlantic Premises, including but not limited to, Industrial Microbes, with Tenant’s and Industrial Microbes’ respective furniture, fixtures, equipment and other personal property removed from the 1010 Atlantic Premises (except from the Subleased Premises). Concurrently with the execution and delivery of this Agreement, Tenant shall deliver to Landlord, and cause Industrial Microbes to deliver to Landlord, copies of the Bay Area Disruptor Subleases in order for Landlord to identify the Subleased Premises that Tenant and Industrial Microbes will continue to occupy. Following the 1010 Atlantic Termination Date and notwithstanding any breach or default of this Agreement by any party hereto, Tenant shall have no right to occupy the 1010 Atlantic Premises except for that portion of the Subleased Premises subleased by Tenant pursuant to a Bay Area Disrupter Sublease, and Industrial Microbes shall have no right to occupy the 1010 Atlantic Premises except for that portion of the Subleased Premises subleased by Industrial Microbes pursuant to a Bay Area Disrupter Sublease. Except for the Subleased Premises, if Tenant or any subtenant or other occupant of the 1010 Atlantic Premises fails to vacate, surrender and deliver exclusive possession of the 1010 Atlantic Premises to Landlord with all of Tenant’s and any subtenants’ or other occupants’ furniture fixtures, equipment and other personal property removed from the 1010 Atlantic Premises by the 1010 Atlantic Termination Date, then, without limitation as to any other rights and remedies of Landlord under the 1010 Atlantic Lease, at law or in equity, Tenant shall be deemed to be a holdover tenant in the 1010 Atlantic Premises subject to the terms and conditions of Article 16 of the 1010 Atlantic Lease, provided however, that, in addition to paying all other amounts due under the 1010 Atlantic Lease, commencing on the day immediately following the 1010 Atlantic Termination Date, Tenant shall pay to Landlord Base Rent for the 1010 Atlantic Premises in the amount of $78,952.62 per month or $2,631.75 per day until the date that Tenant and any subtenants (including Industrial Microbes) or other occupants of the 1010 Atlantic Premises vacate and surrender the 1010 Atlantic Premises (other than the Subleased Premises) to Landlord with all of Tenant’s and any subtenants’ or other occupants’ furniture fixtures, equipment and other personal property removed from the 1010 Atlantic Premises (other than the Subleased Premises).

4. Estoppel. Tenant hereby certifies and acknowledges that as of the date hereof (a) the Leases and this Agreement represent the entire agreement between Landlord and Tenant, (b) Tenant has not assigned or transferred either of the Leases or any interest of Tenant therein, except with respect to the Industrial Microbes Sublease, (c) all improvements or work to be performed by Landlord under the Leases has been performed, (d) Tenant has received all free rent or other rent credits, if any, to which Tenant is entitled under the Leases, (e) to Tenant’s knowledge, Landlord is not in default in any respect under either of the Lease and, as of the date of this Agreement, Tenant is not aware of any facts or circumstances which with the passage of time or the giving of notice, or both, would constitute a default by Landlord under either of the Leases, (f) to Tenant’s knowledge, Tenant does not have any defenses to its obligations under the Leases, (g) there are no offsets or credits against rent payable under either of the Leases, except for the Deferred Rent, which shall be paid to Landlord pursuant to Section 2 above, (h) Tenant delivered to Landlord’s predecessor-in-interest a Letter of Credit under the Leases in the amount of $78,000.00, and (i) Tenant acknowledges and agrees that: (1) the representations herein set forth constitute material consideration to Landlord in entering into this Agreement; (2) such representations are being made by Tenant for purposes of inducing Landlord to enter into this Agreement; and (3) Landlord is relying on such representations in entering into this Agreement. Landlord hereby certifies and acknowledges that, (A) to Landlord’s knowledge, Tenant is not in default in any respect under either of the Leases and, as of the date of this Agreement, Landlord is not aware of any facts or circumstances which with the passage of time or the giving of notice, or both, would constitute a default by Tenant under either of the Leases, (B) Landlord has not assigned all or any portion of Landlord’s interest in the Leases, other than assignments of a security interest in the Leases in connection with any financing of the Project, and (C) Landlord is holding a Letter of Credit under the Leases in the amount of $78,000.00. Each party represents and warrants to the other that it has full power and authority to enter into this Agreement and that each signatory executing this Agreement on its behalf has the authority to execute and deliver the same on behalf of the party hereto for which such signatory is acting.

3

5. Hazardous Materials. Tenant represents and warrants that from the date of the 1020 Atlantic Lease through and including the 1020 Atlantic Termination Date neither Tenant nor its agents, employees, contractors, licensees, subtenants, assignees, concessionaires, or invitees did or shall use, handle, store or dispose of any Hazardous Materials in, on, under or about the 1020 Atlantic Premises, except as expressly permitted under the 1020 Atlantic Lease. Tenant represents and warrants that Tenant has no knowledge that the representation and warranty contained in the immediately prior sentence has been breached by anybody occupying the 1020 Atlantic Premises during such period. Tenant represents and warrants that from the date of the 1010 Atlantic Lease through and including the 1010 Atlantic Termination Date neither Tenant nor its agents, employees, contractors, licensees, subtenants, assignees, concessionaires, or invitees did or shall use, handle, store or dispose of any Hazardous Materials in, on, under or about the 1010 Atlantic Premises, except as expressly permitted under the 1010 Atlantic Lease. Tenant represents and warrants that Tenant has no knowledge that the representation and warranty contained in the immediately prior sentence has been breached by anybody occupying the 1010 Atlantic Premises during such period.

6. Indemnification. Tenant shall indemnify, defend and hold Landlord, and each of Landlord’s partners, members, shareholders, officers, directors, employees, agents, attorneys, investment advisors, portfolio managers, trustees, ancillary trustees, beneficiaries and their affiliates, successors and assigns and their respective partners, members, shareholders, officers, directors, managers and employees (collectively, “Indemnitees”) harmless from and against any and all claims, demands, liability, loss, damage or expenses (including, without limitation, reasonable attorneys’ fees and costs) and all damages, caused by, arising out of or related to (a) Tenant’s breach of the terms of this Agreement or the representations and warranties contained herein, (b) the presence of any Hazardous Materials on, under or about the 1020 Atlantic Premises or the 1010 Atlantic Premises as a result of the acts or omissions of the Tenant or its agents, employees, contractors, licensees, subtenants, assignees, concessionaires or invitees, (c) any injury to or death of persons or damage to the property of Tenant, Landlord or any other person or entity which occurred (i) during the term of the 1020 Atlantic Lease prior to the 1020 Atlantic Termination Date from any cause whatsoever, by reason of the use, occupancy or enjoyment of the 1020 Atlantic Premises by Tenant, except to the extent such injury, death or damage was caused by the gross negligence or willful misconduct of Landlord or (ii) during the term of the 1010 Atlantic Lease prior to the 1010 Atlantic Termination Date from any cause whatsoever, by reason of the use, occupancy or enjoyment of the 1010 Atlantic Premises by Tenant, except to the extent such injury, death or damage was caused by the gross negligence or willful misconduct of Landlord, or (d) any subtenant’s or assignee’s refusal to vacate and surrender the 1020 Atlantic Premises or the 1010 Atlantic Premises in accordance with Section 3 above. Tenant further agrees to indemnify, defend and hold Landlord harmless from all liability whatsoever on account of any mechanics’ or materialmens’ liens, claims or demands arising out of any labor performed or material supplied in connection with or benefiting the 1020 Atlantic Premises prior to the 1020 Atlantic Termination Date or the 1010 Atlantic Premises prior to the 1010 Atlantic Termination Date by or at the request of Tenant or its agents, employees, contractors, licensees, subtenants, assignees, concessionaires or invitees. For purposes of the indemnity provisions hereof, any acts or omission of Tenant, or by employees, agents, assignees, subtenants, contractors or subcontractors of Tenant or others acting for or on behalf of Tenant (whether or not they are negligent, intentional, willful or unlawful), but expressly excluding any acts or omissions by Landlord or Landlord’s employees, agents or invitees, shall be strictly attributable to Tenant. Tenant’s obligation to defend, indemnify and hold the Indemnitees harmless under this Section 6 shall survive the termination of the Leases and this Agreement.

4

7. Release.

(a) For valuable consideration, and the mutual covenants and agreements contained herein, and except as to the rights, liabilities, and obligations arising out of this Agreement, effective as of the 1010 Termination Date with respect to the 1010 Atlantic Lease, and the 1020 Termination Date with respect to the 1020 Atlantic Lease, Tenant fully and forever releases Landlord and each of its partners, members, shareholders, officers, directors, employees, agents, attorneys, investment advisors, portfolio managers, trustees, ancillary trustees, beneficiaries and their affiliates, successors and assigns and their respective partners, members, shareholders, officers, directors, managers and employees, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, losses, costs or expenses of any nature whatsoever, known or unknown, fixed or contingent, which Tenant now has or may hereafter have against Landlord, or any of them, by reason of, arising out of, based upon or relating to any matter, cause or thing whatsoever occurring prior to the 1010 Termination Date with respect to the 1010 Atlantic Lease, and the 1020 Termination Date with respect to the 1020 Atlantic Lease, excluding (i) Landlord’s obligations under this Agreement, and (ii) any obligations of Landlord that expressly survive the termination of the Leases.

(b) For valuable consideration, and the mutual covenants and agreements contained herein, and except as to the rights, liabilities, and obligations arising out of this Agreement, effective as of the 1010 Termination Date with respect to the 1010 Atlantic Lease, and the 1020 Termination Date with respect to the 1020 Atlantic Lease, Landlord fully and forever releases Landlord and each of its partners, members, shareholders, officers, directors, employees, agents, attorneys, investment advisors, portfolio managers, trustees, ancillary trustees, beneficiaries and their affiliates, successors and assigns and their respective partners, members, shareholders, officers, directors, managers and employees, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, losses, costs or expenses of any nature whatsoever, known or unknown, fixed or contingent, which Landlord now has or may hereafter have against Tenant, or any of them, by reason of, arising out of, based upon or relating to any matter, cause or thing whatsoever occurring prior to the 1010 Termination Date with respect to the 1010 Atlantic Lease, and the 1020 Termination Date with respect to the 1020 Atlantic Lease, excluding (i) Tenant’s obligations under this Agreement, (ii) any obligations of Tenant that expressly survive the termination of the Leases.

5

(c) Each of Landlord and Tenant hereby certifies that it has read and understood the provisions of California Civil Code, Section 1542 and has had the opportunity to consult with its own counsel regarding same. Tenant hereby waives any and all rights under California Civil Code, Section 1542, which provides as follows:

“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.”

8. Continuing Liability. Notwithstanding the termination of the 1020 Atlantic Lease and the release of liability provided for herein, Tenant shall remain liable, with respect to the period of its tenancy of the 1020 Atlantic Premises prior to the 1020 Atlantic Termination Date, for the performance of all of its obligations under the 1020 Atlantic Lease (including without limitation, Tenant’s indemnity obligations and Tenant’s obligation to pay rent and other charges), and Landlord shall have all the rights and remedies with respect to such obligations as set forth in the 1020 Atlantic Lease. Notwithstanding the termination of the 1010 Atlantic Lease and the release of liability provided for herein, Tenant shall remain liable, with respect to the period of its tenancy of the 1010 Atlantic Premises prior to the 1010 Atlantic Termination Date, for the performance of all of its obligations under the 1010 Atlantic Lease (including without limitation, Tenant’s indemnity obligations and Tenant’s obligation to pay rent and other charges), and Landlord shall have all the rights and remedies with respect to such obligations as set forth in the 1010 Atlantic Lease.

9. Access to the 1020 Atlantic Premises and the 1010 Atlantic Premises.

(a) In addition to Landlord’s access rights under the 1020 Atlantic Lease, from and after the date of this Agreement, Landlord and the New 1020 Atlantic Tenant shall have the right to enter the 1020 Atlantic Premises upon reasonable prior notice for the purpose of taking measurements and inspecting the 1020 Atlantic Premises as Landlord and the New 1020 Atlantic Tenant deem appropriate to prepare the 1020 Atlantic Premises for the New 1020 Atlantic Tenant under the New 1020 Atlantic Lease. Landlord and Tenant agree to cooperate with each other in scheduling access to the 1020 Atlantic Premises for such purposes.

(b) In addition to Landlord’s access rights under the 1010 Atlantic Lease, from and after the date of this Agreement, Landlord and the Bay Area Disruptor shall have the right to enter the 1010 Atlantic Premises upon reasonable prior notice for the purpose of taking measurements and inspecting the 1010 Atlantic Premises as Landlord and Bay Area Disruptor deem appropriate to prepare the 1010 Atlantic Premises for Bay Area Disruptor under the New 1010 Atlantic Lease. Landlord and Tenant agree to cooperate with each other in scheduling access to the 1010 Atlantic Premises for such purposes.

10. Landlord’s Exculpation. Notwithstanding anything to the contrary contained in this Agreement, Tenant agrees that its sole and exclusive remedy shall be against Landlord’s interest in the 1020 Atlantic Premises and the 1010 Atlantic Premises and that the obligations of Landlord under this Agreement do not constitute personal obligations of the individual partners, whether general or limited, members, directors, officers, shareholders or trustees of Landlord, and Tenant shall not seek recourse against the individual partners, members, directors, officers, shareholders or trustees of Landlord or any of their personal assets for the satisfaction of any liability with respect to this Agreement. Notwithstanding anything to the contrary contained in this Agreement, in no event shall Landlord be liable under any circumstances for any consequential damages, including without limitation, lost profits.

6

11. Brokers. Each of Landlord and Tenant hereby represents and warrants to the other that it has not entered into any agreement or taken any other action which might result in any obligation on the part of the other party to pay any brokerage commission, finder’s fee or other compensation with respect to this Agreement, and each of Landlord and Tenant agrees to indemnify and hold the other harmless from and against any losses, damages, costs or expenses (including without limitation, attorneys’ fees) incurred by the other by reason of any breach or inaccuracy of such representation or warranty.

12. Submission. Submission of this Agreement by Landlord to Tenant for examination and/or execution shall not in any manner bind Landlord and no obligations on Landlord shall arise under this Agreement unless and until this Agreement is fully signed and delivered by Landlord and Tenant.

13. Authorization. Each party to this Agreement represents and warrants to the other party that all consents, approvals and authorizations necessary or required in connection with the transaction contemplated by this Agreement have been obtained.

14. Attorneys’ Fees. If either party commences an action against the other party arising out of or in connection with this Agreement, the prevailing party shall be entitled to recover from the losing party reasonable attorneys’ fees and costs of suit, provided that the prevailing party complies with all notice requirements under applicable state law.

15. Governing Law. This Agreement is made under and shall be construed pursuant to the laws of the State of California.

16. Entire Agreement. This Agreement and the Leases constitute and are intended to constitute the entire agreement of the parties hereto concerning the subject matter hereof. No covenants, agreements, representations or warranties of any kind whatsoever have been made by any party hereto except as specifically set forth herein. All prior discussions and negotiations with respect to the subject matter hereof are superseded by this Agreement.

17. Counterparts; Facsimile, Electronic and Emailed Signatures. This Agreement may be executed in several counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same agreement. A signed copy of this Agreement transmitted by facsimile, email, DocuSign or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original executed copy of this Agreement for all purposes.

18. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of Landlord and Tenant and their respective successors, assigns ad related entities.

[SIGNATURES ON NEXT PAGE]

7

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

	“Landlord”

	G&I IX MARINA VILLAGE RESEARCH PARK LP,
	a Delaware limited partnership

	By:	/s/ Valla Brown
	Name:	Valla Brown
	Title:	Vice President

	“Tenant”

	LINEAGE CELL tHERAPEUTICS, INC.,
	a California corporation

	By:	/s/ Brian M. Culley
	Name:	Brian M. Culley
	Title:	President and CEO

	By:	/s/ Brandi L. Roberts
	Name:	Brandi L. Roberts
	Title:	CFO

	2 SIGNATURES REQUIRED FOR A CALIFORNIA CORPORATION.

	Signature #1		Signature #2
	Chairman of the Board		Secretary
	President		Assistant Secretary
	Vice-President		CFO (or Treasurer)
			Assistant Treasurer

8

EX-101.SCH 3 lctx-20200911.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 lctx-20200911_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 lctx-20200911_pre.xml XBRL PRESENTATION FILE XML 6 form8-k_htm.xml IDEA: XBRL DOCUMENT 0000876343 2020-09-11 2020-09-11 iso4217:USD shares iso4217:USD shares 0000876343 false 8-K 2020-09-11 Lineage Cell Therapeutics, Inc. CA 001-12830 94-3127919 2173 Salk Avenue Suite 200 Carlsbad CA 92008 (442) 287-8990 false false false false Common stock LCTX NYSEAMER false XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Sep. 11, 2020
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Sep. 11, 2020
Entity File Number	001-12830
Entity Registrant Name	Lineage Cell Therapeutics, Inc.
Entity Central Index Key	0000876343
Entity Tax Identification Number	94-3127919
Entity Incorporation, State or Country Code	CA
Entity Address, Address Line One	2173 Salk Avenue
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Carlsbad
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92008
City Area Code	(442)
Local Phone Number	287-8990
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common stock
Trading Symbol	LCTX
Security Exchange Name	NYSEAMER
Entity Emerging Growth Company	false

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://lineagecell.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex10-1.htm lctx-20200911.xsd lctx-20200911_lab.xml lctx-20200911_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "lctx-20200911_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "lctx-20200911_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "lctx-20200911.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "LCTX", "nsuri": "http://lineagecell.com/20200911", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2020-09-11to2020-09-11", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://lineagecell.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2020-09-11to2020-09-11", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 14 0001493152-20-017696-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-017696-xbrl.zip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end